Active Shortage

APO-SAXAGLIPTIN

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-SAXAGLIPTIN in Canada?

Yes. APO-SAXAGLIPTIN 2.5MG has an active shortage reported to Health Canada (last updated October 30, 2026).

Why is APO-SAXAGLIPTIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-SAXAGLIPTIN be available again?

The manufacturer's estimated resolution date is January 8, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~2 months remaining (estimate)

Affected strength2.5MG

Report last updated2026-10-30

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SANDOZ SAXAGLIPTIN

SANDOZ CANADA INCORPORATED

2.5MG · DIN 02468603

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ONGLYZA

ASTRAZENECA CANADA INC

5MG · DIN 02333554

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-SAXAGLIPTIN

APOTEX INC

5MG · DIN 02507498

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02507471

Strength

2.5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

SAXAGLIPTIN

See all SAXAGLIPTIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-10-30

Active Shortage

Disruption of the manufacture of the drug.

2026-10-27

Resolved

Disruption of the manufacture of the drug.

2026-07-10

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244